Nov 23 (Reuters) - Ligand Pharmaceuticals Inc (LGNDD.O) said Swiss drugmaker Roche Holding AG (ROG.VX) was exercising its right to terminate the collaboration and license agreement between the two companies on developing hepatitis C treatment.
Nov 23 (Reuters) - Ligand Pharmaceuticals Inc (LGNDD.O) said Swiss drugmaker Roche Holding AG (ROG.VX) was exercising its right to terminate the collaboration and license agreement between the two companies on developing hepatitis C treatment.
